Pharmaceutical Industry
NHS Left Shift Part 4: What Top Gun Maverick Gets Surprisingly Right About the NHS
Every now and then, life hands you something quite rare, a bit of proper downtime. Recently, I found myself in exactly that position. No meetings, no calls, no slides to finish, no proposals to review. Just a quiet evening and the luxury of choosing something to watch without simultaneously answering emails. I decided to escape…
Read MoreWhy strong NHS market access strategies fail to land – and what the system is actually responding to
Free webinar for pharmaceutical, medtech and device teams Selling to the NHS is never as simple as having a great product and waiting for the system to recognise it. You can have a project that makes complete sense. The clinical case is strong, the pathway benefit is obvious and the clinicians you speak to can…
Read More